Evidence map›Paper›PMID 33410215›Full record

ArticleCancer science2021

Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.

Miku Ishizawa, Undrakh Ganbaatar, Atsuhiko Hasegawa, Natsuko Takatsuka, Nobuyo Kondo, Takeru Yoneda, Kuniko Katagiri, Takao Masuda, Atae Utsunomiya, Mari Kannagi

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Tumor Antigens beyond the Human Exome.International journal of molecular sciences · 2024
    Review
  5. Article
  6. A role for an HTLV-1 vaccine?Frontiers in immunology · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Miku IshizawaDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Undrakh GanbaatarDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Atsuhiko HasegawaDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2974-990X
Natsuko TakatsukaDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Nobuyo KondoDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Takeru YonedaDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Kuniko KatagiriDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Takao MasudaDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Atae UtsunomiyaDepartment of Hematology, Imamura General Hospital, Kagoshima, Japan.
Mari KannagiDeparment of Immunotherapeutics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3433-2658
Tokyo Medical and Dental University · JPImamura Hospital · JP

Funding

Japan Agency for Medical Research and Development 19cm0106365h0001Japan Cancer SocietyJapan Society for the Promotion of Science JP20K07512
6 · The paper itself

Abstract

Activation of CD8

Indexed as

Cell Culture TechniquesAntigens, ViralCancer VaccinesCell Line, TumorCoculture TechniquesCross-PrimingGene Products, taxHistone Deacetylase InhibitorsHLA-A2 AntigenHTLV-I InfectionsHumansHuman T-lymphotropic virus 1ImmunotherapyLeukemia-Lymphoma, Adult T-CellLeukocytes, MononuclearMitomycinAntigens, ViralCancer VaccinesGene Products, taxHistone Deacetylase InhibitorsHLA-A2 AntigenMitomycinATLCTLHTLV-1Taxtumor vaccine

Identifiers

PMID33410215
PMCPMC7935807
OpenAlexW3119339048

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.